Clinical Trial Update: A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing pharmacokinetics, safety, and efficacy of cevostamab in Chinese participants with relapsed or refractory multiple myeloma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cevostamab (cevostamab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING